MSTN and obesity disorder: In addition, Tang et al. 2016 [50] confirmed the negative effect of myostatin on bone by demonstrating that the administration of polyclonal myostatin antibody prevented bone loss and microarchitecture deterioration due to diet-induced obesity in rats.